PL2598503T3 - Pochodne cis-tetrahydro-spiro (cykloheksano-1,1'-pirydo[3,4-b]-indolo)-4-aminy - Google Patents

Pochodne cis-tetrahydro-spiro (cykloheksano-1,1'-pirydo[3,4-b]-indolo)-4-aminy

Info

Publication number
PL2598503T3
PL2598503T3 PL11737904T PL11737904T PL2598503T3 PL 2598503 T3 PL2598503 T3 PL 2598503T3 PL 11737904 T PL11737904 T PL 11737904T PL 11737904 T PL11737904 T PL 11737904T PL 2598503 T3 PL2598503 T3 PL 2598503T3
Authority
PL
Poland
Prior art keywords
cyclohexan
pyrido
indol
spiro
tetrahydro
Prior art date
Application number
PL11737904T
Other languages
English (en)
Inventor
Klaus Linz
Saskia Zemolka
Bert Nolte
Stefan Schunk
Hans Schick
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44315152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2598503(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of PL2598503T3 publication Critical patent/PL2598503T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL11737904T 2010-07-28 2011-07-27 Pochodne cis-tetrahydro-spiro (cykloheksano-1,1'-pirydo[3,4-b]-indolo)-4-aminy PL2598503T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10007822 2010-07-28
PCT/EP2011/003771 WO2012013343A1 (de) 2010-07-28 2011-07-27 Cis-tetrahydro-spiro(cyclohexan-1,1'-pyrido[3,4-b]indol)-4-amin-derivate
EP11737904.0A EP2598503B1 (de) 2010-07-28 2011-07-27 Cis-tetrahydro-spiro(cyclohexan-1,1'-pyrido[3,4-b]indol)-4-amin-derivate

Publications (1)

Publication Number Publication Date
PL2598503T3 true PL2598503T3 (pl) 2014-08-29

Family

ID=44315152

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14000496T PL2740476T3 (pl) 2010-07-28 2011-07-27 Pochodne cis-tetrahydro-spiro(cykloheksano-1,1'-pirydo[3,4-b]indolo)-4-aminy
PL11737904T PL2598503T3 (pl) 2010-07-28 2011-07-27 Pochodne cis-tetrahydro-spiro (cykloheksano-1,1'-pirydo[3,4-b]-indolo)-4-aminy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL14000496T PL2740476T3 (pl) 2010-07-28 2011-07-27 Pochodne cis-tetrahydro-spiro(cykloheksano-1,1'-pirydo[3,4-b]indolo)-4-aminy

Country Status (31)

Country Link
US (3) US20120029006A1 (pl)
EP (2) EP2740476B1 (pl)
JP (1) JP5898193B2 (pl)
KR (1) KR101927054B1 (pl)
CN (1) CN103025732B (pl)
AR (1) AR082393A1 (pl)
AU (1) AU2011285217B8 (pl)
BR (1) BR112013003642A2 (pl)
CA (1) CA2806633C (pl)
CL (1) CL2013000266A1 (pl)
CO (1) CO6650378A2 (pl)
CY (2) CY1115186T1 (pl)
DK (2) DK2740476T3 (pl)
EC (1) ECSP13012409A (pl)
ES (2) ES2708930T3 (pl)
HR (2) HRP20140569T1 (pl)
HU (1) HUE042732T2 (pl)
IL (1) IL223756A (pl)
LT (1) LT2740476T (pl)
MX (1) MX2013000751A (pl)
NZ (1) NZ607529A (pl)
PE (1) PE20130808A1 (pl)
PL (2) PL2740476T3 (pl)
PT (2) PT2740476T (pl)
RS (2) RS58036B1 (pl)
RU (1) RU2592283C2 (pl)
SI (2) SI2740476T1 (pl)
TR (1) TR201821273T4 (pl)
TW (1) TWI582092B (pl)
WO (1) WO2012013343A1 (pl)
ZA (1) ZA201301505B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015022509A2 (pt) * 2013-03-15 2017-07-18 Gruenenthal Gmbh forma cristalina de cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclohexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
SI3402782T1 (sl) 2016-01-13 2020-11-30 Grunenthal Gmbh 8-amino-2-okso-1,3-diaza-spiro-(4,5)-dekanski derivati
CA3011176C (en) 2016-01-13 2023-09-19 Grunenthal Gmbh 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
CA3011180A1 (en) * 2016-01-13 2017-07-20 Grunenthal Gmbh 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
SI3402784T1 (sl) 2016-01-13 2020-07-31 Gruenenthal Gmbh Derivati 3-((hetero)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-(4.5)-dekana
BR112018014302B1 (pt) 2016-01-13 2023-10-17 Grünenthal GmbH Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano
PL3838274T3 (pl) 2016-01-26 2024-04-02 Intra-Cellular Therapies, Inc. Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
TW201832765A (zh) * 2017-02-24 2018-09-16 德商歌林達有限公司 膀胱內投藥用於治療膀胱痛之組合物
TW201908295A (zh) 2017-07-12 2019-03-01 德商歌林達有限公司 １，３－二氮雜－螺－［３．４］－辛烷衍生物
JP2019073493A (ja) * 2017-10-17 2019-05-16 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ヴルヴォディニアの治療
CN112040940A (zh) 2018-03-23 2020-12-04 细胞内治疗公司 有机化合物
WO2020030777A1 (en) 2018-08-10 2020-02-13 Grünenthal GmbH Composition for treating urinary frequency and/or urinary urgency
JP7520013B2 (ja) 2018-12-17 2024-07-22 イントラ－セルラー・セラピーズ・インコーポレイテッド 置換複素環縮合γ－カルボリンの合成
WO2020131899A1 (en) 2018-12-17 2020-06-25 Intra-Cellular Therapies, Inc. Organic compound
US12195463B2 (en) 2018-12-21 2025-01-14 Intra-Cellular Therapies, Inc. Organic compounds
JP7649743B2 (ja) 2018-12-21 2025-03-21 イントラ－セルラー・セラピーズ・インコーポレイテッド 有機化合物
CA3134674A1 (en) * 2019-04-04 2020-10-08 Intra-Cellular Therapies, Inc. Methods of treating neuropathic pain
CN119241381A (zh) 2019-12-26 2025-01-03 吉尔伽美什制药公司 芳基环己基胺衍生物及其在精神障碍的治疗中的用途
RU2725197C1 (ru) * 2020-02-12 2020-06-30 федеральное государственное бюджетное образовательное учреждение высшего образования «Ижевская государственная медицинская академия» Министерства здравоохранения Российской Федерации Метод оценки висцеральной гиперчувствительности
KR20260008838A (ko) 2020-02-18 2026-01-16 길가메쉬 파마슈티컬스, 인코포레이티드 기분 장애 치료에 사용되기 위한 특이적 트립타민
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof
US12129234B1 (en) 2023-08-03 2024-10-29 Gilgamesh Pharmaceuticals, Inc. Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine
US12180158B1 (en) 2023-08-03 2024-12-31 Gilgamesh Pharmaceuticals, Inc. Crystalline fumarate salts of n-ethyl-2-(5-fluoro-1H-indol-3-yl)-n-methylethan-1-amine

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10323172A1 (de) 2003-05-22 2004-12-09 Ina-Schaeffler Kg Treiberstufe für ein Solenoidventil
DE10360792A1 (de) 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360793A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102004019502A1 (de) 2004-04-22 2005-11-17 Rheinmetall Landsysteme Gmbh Munitionsmagazin
DE102004039382A1 (de) 2004-08-13 2006-02-23 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US8425881B2 (en) 2005-03-18 2013-04-23 Colgate-Palmolive Company Antibacterial 3′,5-disubstituted 2,4′-dihydroxybiphenyl compounds, derivatives and related methods
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
WO2006110856A2 (en) 2005-04-12 2006-10-19 The Ohio State University All wheel drive electrically-variable transmission
AU2007233564A1 (en) 2006-03-30 2007-10-11 Innovative Dairy Products Pty Ltd As Trustee For The Participants Of The Cooperative Research Centre For Innovative Dairy Products Chromosomal blocks as markers for traits
WO2007117173A1 (en) 2006-04-07 2007-10-18 Closed Joint Stock Company 'biocad' Fluid dispensing system, methods and products
DE102006019597A1 (de) * 2006-04-27 2007-10-31 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102006033114A1 (de) 2006-07-18 2008-01-24 Grünenthal GmbH Spirocyclische Azaindol-Derivate
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
WO2008100941A2 (en) 2007-02-12 2008-08-21 Correlogic Systems Inc. A method for calibrating an analytical instrument
PT2260042E (pt) * 2008-03-27 2011-12-06 Gruenenthal Gmbh Derivados de ciclo-hexano espirocíclicos substituídos
BR112015022509A2 (pt) * 2013-03-15 2017-07-18 Gruenenthal Gmbh forma cristalina de cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclohexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina

Also Published As

Publication number Publication date
PT2740476T (pt) 2019-03-18
CN103025732A (zh) 2013-04-03
US20160159787A1 (en) 2016-06-09
CA2806633C (en) 2019-08-20
ZA201301505B (en) 2014-08-27
EP2740476A1 (de) 2014-06-11
NZ607529A (en) 2014-05-30
CA2806633A1 (en) 2012-02-02
CN103025732B (zh) 2016-06-01
AU2011285217A1 (en) 2013-03-14
TW201204724A (en) 2012-02-01
HRP20140569T1 (hr) 2014-08-15
SI2740476T1 (sl) 2019-02-28
KR101927054B1 (ko) 2018-12-10
DK2598503T3 (da) 2014-04-14
AU2011285217A8 (en) 2014-04-24
PL2740476T3 (pl) 2019-06-28
HK1183660A1 (en) 2014-01-03
EP2598503A1 (de) 2013-06-05
IL223756A (en) 2015-06-30
DK2740476T3 (en) 2019-01-14
JP2013532669A (ja) 2013-08-19
US20170313703A1 (en) 2017-11-02
CO6650378A2 (es) 2013-04-15
WO2012013343A1 (de) 2012-02-02
ECSP13012409A (es) 2013-06-28
TR201821273T4 (tr) 2019-01-21
AR082393A1 (es) 2012-12-05
EP2598503B1 (de) 2014-03-26
SI2598503T1 (sl) 2014-05-30
RS53341B (sr) 2014-10-31
PT2598503E (pt) 2014-05-06
CY1115186T1 (el) 2017-01-04
CY1120993T1 (el) 2019-12-11
EP2740476B1 (de) 2018-12-05
AU2011285217B2 (en) 2014-04-10
BR112013003642A2 (pt) 2016-09-06
AU2011285217B8 (en) 2014-04-24
ES2474644T3 (es) 2014-07-09
RS58036B1 (sr) 2019-02-28
PE20130808A1 (es) 2013-07-06
US20120029006A1 (en) 2012-02-02
RU2013108696A (ru) 2014-09-10
JP5898193B2 (ja) 2016-04-06
MX2013000751A (es) 2013-01-29
HRP20182078T1 (hr) 2019-02-08
CL2013000266A1 (es) 2013-05-24
KR20130098315A (ko) 2013-09-04
TWI582092B (zh) 2017-05-11
HUE042732T2 (hu) 2019-07-29
RU2592283C2 (ru) 2016-07-20
LT2740476T (lt) 2018-12-27
ES2708930T3 (es) 2019-04-12

Similar Documents

Publication Publication Date Title
PL2740476T3 (pl) Pochodne cis-tetrahydro-spiro(cykloheksano-1,1'-pirydo[3,4-b]indolo)-4-aminy
ZA201206630B (en) Hetaryl-[1,8]naphthyridine derivatives
EP2480080A4 (en) PYRIDO [3,4-B] INDOLES AND METHODS OF USE
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
EP2480079A4 (en) PYRIDO- (3,4-B-) INDOLE AND USE METHOD THEREFOR
ZA201209632B (en) Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof
IL215725A0 (en) 3-([1,2,3]-triazol-4-yl)pyrrolo[2,3-b]pyridine derivatives
IL200497A0 (en) Spirocyclic cyclohexane derivatives
IL211241A0 (en) 7-azaindole derivatives
PL2531505T3 (pl) Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami
IL222080B (en) 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives
IL221479A0 (en) Triazolo [4,5-b] pyridin derivatives
ZA201302112B (en) 1,4-oxazepane derivatives
IL222351A (en) Process for making derivatives 4,1-diethylene-di (3-pyroline) -tetrone
ZA201308497B (en) 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
GB2476643B (en) 1,4-Dihydro-1,4-dioxonaphtalene derivatives as anticoagulants
PL390846A1 (pl) Pochodne 5,11-dimetylo-5H-indolo[2,3-b]chinoliny
PL2531504T3 (pl) Sposób wytwarzania roztworów kompleksów metali z 3,7-diazabicyklo[3.3.1]nonanem
HK1176060A (en) Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
HK1186730A (en) 1,4-oxazepane derivatives
AU2010901109A0 (en) Adjustable, multi-purpose plus
HK1167854A (en) [1,2,4]triazolo [4,3-b]pyridazines as ligands of the androgen receptor
HK1187608A (en) Indole derivatives
HK1179251A (en) Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof
HK1167997A (en) Pyrido [4,3-b] indoles and methods of use